US6126832A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Composition for dialysis and shock treatment
Assignee: Individual
•
Filing: 1997-10-31
•
Granted: 2000-10-03
•
Expires: 2017-10-31
Abstract
Abstract A dialysis system and method for removing toxic matter from the large intestine comprises an input tube, an output tube concentric with the input tube, both of which tubes are to be inserted in the large intestine an input pressure pump connected to deliver filtrate solution from an input container to the input tube, and an output suction pump connected to the output tube to remove filtrate solution. Pressure gauges control the input and output pumps so that an input pressure level of 75 mm Hg is not exceeded, and so that the output suction pump is disabled unless the input pressure level exceeds 45 mm Hg. A filtrate solution composition comprising a vasodilator of niacin, a high molecular weight protein in the form of casein, a mineral constituents and other components is also provided. The composition may be formed of electrolytes, buffers and a high molecular weight osmotic agent. The system and method may be adapted to treat shock. A shock treatment composition may comprise electrolytes, buffers and a rehydrating agent.
Inventors
- 👤 Andrew Stone
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 04:51
CPC Classifications
A; A61; A61M; A61M1/00; A61M1/14; A61M1/28; A61M1/287; A61K; A61K33/00; A61K33/14; A61K38/00; A61K38/16; A61K38/17; A61K38/1703; A61K38/1709; A61M1/281; A61M1/285; A61M1/71; A61M1/77; A61P; A61P7/00; A61P7/08; A61M25/00; A61M25/10; A61M2025/1043; A61M2025/1052; A61M2210/00; A61M2210/10; A61M2210/1042; A61M2210/1064; A61M25/1011
Claims Analysis
Total Claims: 23
Claim 1
Independent Claim
70 words
A filtrate composition for use in dialysis via the colon, comprising: a vasodilator a high molecular weight protein being present in a sufficient amount to effect osmotic pressure to achieve diffusion of elements across the large intestine membrane into the filtrate and having a sufficient molecular weight such that it is not readily absorbed in the colonic mucosa; and mineral constituents for maintaining proper serum levels in the large intestine.
Claim 2
Dependent Claim
70 words
A filtrate composition for use in dialysis via the colon, comprising: a vasodilator a high molecular weight protein being present in a sufficient amount to effect osmotic pressure to achieve diffusion of elements across the large intestine membrane into the filtrate and having a sufficient molecular weight such that it is not readily absorbed in the colonic mucosa; and mineral constituents for maintaining proper serum levels in the large intestine.
Claim 3
Dependent Claim
11 words
The composition according to claim 1, wherein the vasodilator is niacin.
Claim 4
Dependent Claim
14 words
The composition according to claim 1, wherein the high molecular weight protein is casein.
Claim 5
Dependent Claim
30 words
The composition according to claim 1, wherein the mineral constituents are selected from the group consisting of sodium chloride, potassium gluconate, magnesium citrate, calcium lactate, ferrous citrate and zinc citrate.
Claim 6
Dependent Claim
10 words
The composition according to claim 1, further comprising ascorbic acid.
Claim 7
Dependent Claim
10 words
The composition according to claim 1, further comprising lemon bioflavinoids.
Claim 8
Dependent Claim
9 words
The composition according to claim 1, further comprising rutin.
Claim 9
Dependent Claim
9 words
The composition according to claim 1, further comprising hesperidin.
Claim 10
Dependent Claim
9 words
The composition according to claim 1, further comprising acerola.
Claim 11
Dependent Claim
22 words
The composition according to claim 1, further comprising sodium bicarbonate and glucuronic acid to maintain a buffered pH of about 7.38 pH.
Claim 12
Dependent Claim
56 words
A filtrate composition for use in dialysis via the colon, comprising: electrolytes for establishing electrolyte concentrations; buffers for maintaining acid-base equilibrium; and a high molecular weight osmotic agent being present in a sufficient amount for removing nitrogenous waste, said agent having a sufficient molecular weight such that it is not readily absorbed in the colonic mucosa.
Claim 13
Dependent Claim
56 words
A filtrate composition for use in dialysis via the colon, comprising: electrolytes for establishing electrolyte concentrations; buffers for maintaining acid-base equilibrium; and a high molecular weight osmotic agent being present in a sufficient amount for removing nitrogenous waste, said agent having a sufficient molecular weight such that it is not readily absorbed in the colonic mucosa.
Claim 14
Dependent Claim
22 words
The composition according to claim 11, wherein the electrolytes are selected from the group consisting of sodium, potassium, magnesium, calcium and chloride.
Claim 15
Dependent Claim
19 words
The composition according to claim 11, wherein the buffers are selected from the group consisting of bicarbonate and lactate.
Claim 16
Dependent Claim
23 words
The composition according to claim 11, wherein the high molecular weight osmotic agent is selected from the group consisting of maltodextrin and casein.
Claim 17
Dependent Claim
10 words
The composition according to claim 11, further comprising a vasodilator.
Claim 18
Dependent Claim
23 words
The composition according to claim 11, further including an ammonium binding ingredient selected from the group consisting of activated charcoal and synthetic sorbents.
Claim 19
Dependent Claim
17 words
The composition according to claim 11, further including an ingredient to promote increased creatinine binding and removal.
Claim 20
Dependent Claim
12 words
The composition according to claim 17, wherein the ingredient is zirconium phosphate.
Claim 21
Dependent Claim
11 words
The composition according to claim 11, further including an iontophoretic component.
Claim 22
Dependent Claim
58 words
A filtrate composition for use in dialysis, comprising: a vasodilator; a high molecular weight protein to effect osmotic pressure to achieve diffusion of elements across the large intestine membrane into the filtrate; mineral constituents for maintaining proper serum levels in the large intestine; and sodium bicarbonate and glucuronic acid to maintain a buffered pH of about 7.38 pH.
Claim 23
Dependent Claim
58 words
A filtrate composition for use in dialysis, comprising: a vasodilator; a high molecular weight protein to effect osmotic pressure to achieve diffusion of elements across the large intestine membrane into the filtrate; mineral constituents for maintaining proper serum levels in the large intestine; and sodium bicarbonate and glucuronic acid to maintain a buffered pH of about 7.38 pH.
References Cited (Backward Citations)
US3669880A
Cited
US4133891A
Cited
US4761237A
Cited
US4886789A
Cited
US4906616A
Cited
US5039609A
Cited
US4889634A
Cited
US5108767A
Cited
US5631025A
Cited
US5578576A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2003-10-03 | 2004-04-03 | 2004-10-03 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2007-10-03 | 2008-04-03 | 2008-10-03 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2011-10-03 | 2012-04-03 | 2012-10-03 | $7700.00 | Window Closed / Lapsed |